LYELL IMMUNOPHARMA IN
0.9205
27-November-24 16:45:00
15 minutes delayed
Stocks
-0.0032
-0.35%
Today's range
0.9200 - 0.9969
ISIN
N/A
Source
NASDAQ
-
Lyell Immunopharma Reports Second Quarter Financial Results and Business Highlights
04 Aug 2022 16:05:03 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Goldman Sachs Global Healthcare Conference
07 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
10 May 2022 16:05:02 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
04 May 2022 16:05:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
08 Mar 2022 16:45:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Gary Lee, Ph.D. as Chief Scientific Officer
31 Jan 2022 16:05:00 By Nasdaq GlobeNewswire
-
24 Jan 2022 08:00:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 16:05:01 By Nasdaq GlobeNewswire
-
16 Dec 2021 16:05:00 By Nasdaq GlobeNewswire
-
15 Dec 2021 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Return of Dr. Rick Klausner as Board Chair
02 Dec 2021 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
12 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Morgan Stanley Global Healthcare Conference
08 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
12 Aug 2021 16:05:02 By Nasdaq GlobeNewswire